Table 3:
Patient follow-up
| Group 1 (1999–2006) | Group 2 (2007–2013) | Group 3 (2014–2020) | |
|---|---|---|---|
| Total number of patients | 23 | 7 | 16 |
| Number of TEVAR, n (%) | 17 (74) | 7 (100) | 16 (100) |
| Deaths, n (%) | 7 (30) | 2 (28) | 2 (12.5) |
| Loss of FU before 1 year, n (%) | 7 (30) | 3 (43) | 8 (50) |
| FU >1 year, n (%) | 9 (39) | 2 (29) | 7 (44) |
| FU >3 years, n (%) | 8 (35) | 1 (14) | 3 (19) |
| FU >5 years, n (%) | 6 (26) | 1 (14) | 1 (6) |
| FU >10 years, n (%) | 6 (26) | 1 (14) | 0 (0) |
TEVAR: thoracic endovascular repair; FU: follow-up